Direct gene therapy for bone regeneration: Gene gelivery, animal models, and outcome measures

Tissue Engineering - Part B: Reviews

Volumn 16, Issue 1, 2010, Pages 13-20

  Pelled, Gadi ^a,b   Ben Arav, Ayelet ^a   Hock, Colleen ^c   Reynolds, David G ^c   Yazici, Cemal ^c   Zilberman, Yoram ^a   Gazit, Zulma ^a,b   Awad, Hani ^c   Gazit, Dan ^a,b   Schwarz, Edward M ^c  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; BIODISTRIBUTIONS; BONE HEALING; BONE REGENERATION; BONE REPAIR; CELL ISOLATION; CELL-MEDIATED GENE THERAPY; CELLULAR COMPONENTS; CLINICAL USE; CRANIOFACIAL; FRACTURE HEALING; GENE DELIVERY; IN-VIVO; OSTEOGENIC; POTENTIAL SOLUTIONS; RESEARCH EFFORTS;

ANIMALS; BIOACTIVITY; BONE; CELL CULTURE; FRACTURE; GENE THERAPY; GENE TRANSFER; PHYSIOLOGICAL MODELS;

GENE EXPRESSION;

BONE REGENERATION; BONE REMODELING; CELL BASED GENE THERAPY; CELL ISOLATION; FRACTURE; FRACTURE HEALING; GENE EXPRESSION; GENE TARGETING; HUMAN; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT;

ANIMALS; BONE REGENERATION; FRACTURE HEALING; GENE THERAPY; GENE TRANSFER TECHNIQUES; MODELS, ANIMAL; TREATMENT OUTCOME;

ANIMALIA;

EID: 76749092694     PISSN: 19373368     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.teb.2009.0156     Document Type: Review

References (78)

1. Einhorn, T.A. The science of fracture healing. J Orthop Trauma 19, S4, 2005.
2. Hollinger, J.O., and Kleinschmidt, J.C. The critical size defect as an experimental model to test bone repair materials. J Craniofac Surg 1, 60, 1990.
3. Covey, D., Aaron, R., Born, C., Calhoun, J., Einhorn, T., Hayda, R., Levin, L., Mazurek, M., Murray, C., Powell, E., Schwarz, E., and Wenke, J. Orthopaedic war injuries: from combat casualty care to definitive treatment: a current review of clinical advances, basic science, and research opportunities. Instr Course Lect 57, 65 2008.
4. Covey, D. Combat orthopaedics: a view from the trenches. J Am Acad Orthop Surg 14, S10, 2006.
5. Owens, B.D., Kragh, J.F., Wenke, J.C., Macaitis, J., Wade, C.E., and Holcomb, J.B. Combat wounds in operation Iraqi freedom and operation enduring freedom. J Trauma Inj Infect Crit Care 64, 295, 2008.
6. Owens, B.D., Kragh, J.F., Macaitis, J., Svoboda, S.J., and Wenke, J.C. Characterization of extremity wounds in operation Iraqi freedom and operation enduring freedom. J Or-thop Trauma 21, 254, 2007.
7. Lieberman, J.R., Ghivizzani, S.C., and Evans, C.H. Gene transfer approaches to the healing of bone and cartilage. Mol Ther 6, 141, 2002.
8. Awad, H.A., Zhang, X., Reynolds, D.G., Guldberg, R.E., O'Keefe, R.J., and Schwarz, E.M. Recent advances in gene delivery for structural bone allografts. Tissue Eng 13, 1973, 2007.
9. Betz, V.M., Betz, O.B., Glatt, V., Gerstenfeld, L.C., Einhorn, T.A., Bouxsein, M.L., Vrahas, M.S., and Evans, C.H. Healing of segmental bone defects by direct percutaneous gene delivery: effect of vector dose. Hum Gene Ther 18, 907, 2007.
10. Betz, O.B., Betz, V.M., Nazarian, A., Egermann, M., Ger-stenfeld, L.C., Einhorn, T.A., Vrahas, M.S., Bouxsein, M.L., and Evans, C.H. Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Gene Ther 14, 1039, 2007.
11. Egermann, M., Baltzer, A.W., Adamaszek, S., Evans, C., Robbins, P., Schneider, E., and Lill, C.A. Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep. Hum Gene Ther 17, 507, 2006.
12. Egermann, M., Lill, C.A., Griesbeck, K., Evans, C.H., Robbins, P.D., Schneider, E., and Baltzer, A.W. Effect of BMP-2 gene transfer on bone healing in sheep. Gene Ther 13, 1290, 2006.
13. Betz, O.B., Betz, V.M., Nazarian, A., Pilapil, C.G., Vrahas, M.S., Bouxsein, M.L., Gerstenfeld, L.C., Einhorn, T.A., and Evans, C.H. Direct percutaneous gene delivery to enhance healing of segmental bone defects. J Bone Joint Surg Am 88A, 355, 2006.
14. Southwood, L.L., Frisbie, D.D., Kawcak, C.E., Ghivizzani, S.C., Evans, C.H., and McIlwraith, C.W. Evaluation of Ad-BMP-2 for enhancing fracture healing in an infected defect fracture rabbit model. J Orthop Res 22, 66, 2004.
15. Baltzer, A.W.A., Lattermann, C., Whalen, J.D., Wooley, P., Weiss, K., Grimm, M., Ghivizzani, S.C., Robbins, P.D., and Evans, C.H. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther 7, 734, 2000.
16. Tarkka. T., Sipola, A., Jä msä, T., Soini, Y., Ylä-Herttuala, S., Tuukkanen, J., and Hautala, T. Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues. J Gene Med 5, 560, 2003.
17. Raper, S.E., Chirmule, N., Lee, F.S., Wivel, N.A., Bagg, A., Gao, G.P., Wilson, J.M., and Batshaw, M.L. Fatal systemic inflammatory response syndrome in a ornithine transcar-bamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 80, 148, 2003.
18. Sheyn, D., Kimelman-Bleich, N., Pelled, G., Zilberman, Y., Gazit, D., and Gazit, Z. Ultrasound-based nonviral gene delivery induces bone formation in vivo. Gene Ther 15, 257, 2008.
19. Osawa, K., Okubo, Y., Nakao, K., Koyama, N., and Bessho, K. Osteoinduction by microbubble-enhanced transcutaneous sonoporation of human bone morphogenetic protein-2. J Gene Med 11, 633, 2009.
20. Kishimoto, K.N., Watanabe, Y., Nakamura, H., and Koku-bun, S. Ectopic bone formation by electroporatic transfer of bone morphogenetic protein-4 gene. Bone 31, 340, 2002.
21. Kawai, M., Bessho, K., Kaihara, S., Sonobe, J., Oda, K., Iizuka, T., and Maruyama, H. Ectopic bone formation by human bone morphogenetic protein-2 gene transfer to skeletal muscle using transcutaneous electroporation. Hum Gene Ther 14, 1547, 2003.
22. Kawai, M., Bessho, K., Maruyama, H., Miyazaki, J.I., and Yamamoto, T. Human BMP-2 gene transfer using transcu-taneous in vivo electroporation induced both in-tramembranous and endochondral ossification. Anat Rec A Discov Mol Cell Evol Biol 287A, 1264, 2005.
23. Kawai, M., Bessho, K., Maruyama, H., Miyazaki, J., and Yamamoto, T. Simultaneous gene transfer of bone mor-phogenetic protein (BMP)-2 and BMP-7 by in vivo electro-poration induces rapid bone formation and BMP-4 expression. BMC Musculoskelet Disord 7, 2006.
24. Kotajima, S., Kishimoto, K.N., Watanuki, M., Hatori, M., and Kokubun, S. Gene expression analysis of ectopic bone formation induced by electroporatic gene transfer of BMP4. Upsala J Med Sci 111, 231, 2006.
25. Busse, J.W., Kaur, J., Mollon, B., Bhandari, M., Tornetta, P., Schuenemann, H.J., and Guyatt, G.H. Low intensity pulsed ultrasonography for fractures: systematic review of randomised controlled trials. Br Med J 338, b351, 2009.
26. Al-Sakere, B., André, F., Bernat, C., Connault, E., Opolon, P., Davalos, R., Rubinsky, B., and Mir, L. Tumor ablation with irreversible electroporation. PLoS ONE 2, e1135, 2007.
27. Campana, L.G., Mocellin, S., Basso, M., Puccetti, O., De Salvo, G.L., Chiarion-Sileni, V., Vecchiato, A., Corti, L., Rossi, C.R., and Nitti, D. Bleomycin-based electro-chemotherapy: clinical outcome from a single institution's experience with 52 patients. Ann Surg Oncol 16, 191, 2009.
28. Daud, A.I., DeConti, R.C., Andrews, S., Urbas, P., Riker, A.I., Sondak, V.K., Munster, P.N., Sullivan, D.M., Ugen, K.E., Messina, J.L., and Heller, R. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 26, 5896, 2008.
29. Granot, Y., and Rubinsky, B. Methods of optimization of electrical impedance tomography for imaging tissue elec-troporation. Physiol Meas 28, 1135, 2007.
30. Fang, J.M., Zhu, Y.Y., Smiley, E., Bonadio, J., Rouleau, J.P., Goldstein, S.A., McCauley, L.K., Davidson, B.L., and Roessler, B.J. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci USA 93, 5753, 1996.
31. Bonadio, J., Smiley, E., Patil, P., and Goldstein, S. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 5, 753, 1999.
32. Huang, Y.C., Simmons, C., Kaigler, D., Rice, K.G., and Mooney, D.J. Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4). Gene Ther 12, 418, 2005.
33. Lutz, R., Park, J., Felszeghy, E., Wiltfang, J., Nkenke, E., and Schlegel, K.A. Bone regeneration after topical BMP-2-gene delivery in circumferential peri-implant bone defects. Clin Oral Implants Res 19, 590, 2008.
34. Endo, M., Kuroda, S., Kondo, H., Maruoka, Y., Ohya, K., and Kasugai, S. Bone regeneration by modified gene-activated matrix: effectiveness in segmental tibial defects in rats. Tissue Eng 12, 489, 2006.
35. Brigman, B.E., Hornicek, F.J., Gebhardt, M.C., and Mankin, H.J. Allografts about the knee in young patients with high-grade sarcoma. Clin Orthop Relat Res 421, 232, 2004.
36. Jaffe, K.A., Morris, S.G., Sorrell, R.G., Gebhardt, M.C., and Mankin, H.J. Massive bone allografts for traumatic skeletal defects. South Med J 84, 975, 1991.
37. Mankin, H.J., Gebhardt, M.C., and Tomford, W.W. The use of frozen cadaveric allografts in the management of patients with bone-tumors of the extremities. Orthop Clin North Am 18, 275, 1987.
38. Goldberg, V., and Stevenson, S. The biology of bone grafts. Semin Arthroplasty 4, 58, 1993.
39. Burchardt, H., Glowczewskie, F., Rudner, C., Enneking, W.F., and Jones, H. Freeze-dried allogeneic segmental cortical-bone grafts in dogs. J Bone Joint Surg Am 60, 1082, 1978.
40. Chalmers, J. Transplantation immunity in bone homograft-ing. J Bone Joint Surg Br 41, 160, 1959.
41. Summers, B.N., and Eisenstein, S.M. Donor site pain from the Ilium-a complication of lumbar spine fusion. J Bone Joint Surg Br 71, 677, 1989.
42. Younger, E., and Chapman, M. Morbidity at bone graft donor sites. J Orthop Trauma 3, 192, 1989.
43. Berrey, B.H., Lord, C.F., Gebhardt, M.C., and Mankin, H.J. Fractures of allografts-frequency, treatment, and end-results. J Bone Joint Surg Am 72A, 825, 1990.
44. Lord, C.F., Gebhardt, M.C., Tomford, W.W., and Mankin, H.J. Infection in bone allografts-incidence, nature, and treatment. J Bone Joint Surg Am 70A, 369, 1988.
45. Wheeler, D.L., and Enneking, W.F. Allograft bone decreases in strength in vivo over time. Clin Orthop Relat Res 435, 36, 2005.
46. Enneking, W.E., and Campanacci, D.A. Retrieved human allografts-a clinicopathological study. J Bone Joint Surg Am 83A, 971, 2001.
47. Hornicek, F.J., Gebhardt, M.C., Tomford, W.W., Sorger, J.I., Zavatta, M., Menzner, J.P., and Mankin, H.J. Factors affecting nonunion of the allograft-host junction. Clin Orthop Relat Res 382, 87, 2001.
48. Ito, H., Koefoed, M., Tiyapatanaputi, P., Gromov, K., Goater, J.J., Carmouche, J., Zhang, X., Rubery, P.T., Rabinowitz, J., Samulski, R.J., Nakamura, T., Soballe, K., O'Keefe, R.J., Boyce, B.F., and Schwarz, E.M. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med 11, 291, 2005.
49. Koefoed, M., Ito, H., Gromov, K., Reynolds, D.G., Awad, H.A., Rubery, P.T., Ulrich-Vinther, M., Soballe, K., Guld-berg, R.E., Lin, A.S.P., O'Keefe, R.J., Zhang, X.P., and Schwarz, E.M. Biological effects of rAAV-caAlk2 coating on structural allograft healing. Mol Ther 12, 212, 2005.
50. Stevenson, S., Li, X.Q., Davy, D.T., Klein, L., and Goldberg, V.M. Critical biological determinants of incorporation of non-vascularized cortical bone grafts-quantification of a complex process and structure. J Bone Joint Surg Am 79A, 1, 1997.
51. Lee, F.Y.I., Hazan, E.J., Gebhardt, M.C., and Mankin, H.J. Experimental model for allograft incorporation and allograft fracture repair. J Orthop Res 18, 303, 2000.
52. Henry, W.B., Schachar, N.S., Wadsworth, P.L., Castronovo, F.P., and Mankin, H.J. Feline model for the study of frozen osteoarticular hemijoint transplantation-qualitative and quantitative assessment of bone healing. Am J Vet Res 46, 1714, 1985.
53. Aebi, M., Regazzoni, P., and Schwarzenbach, O. Segmental bone-grafting-comparison of different types of graft in dogs. Int Orthop 13, 101, 1989.
54. Kohler, P., Ehrnberg, A., and Kreicbergs, A. Osteogenic enhancement of diaphyseal reconstruction-comparison of bone-grafts in the rabbit. Acta Orthop Scand 61, 42, 1990.
55. Schwarz, N., Schlag, G., Thurnher, M., Eschberger, J., Din-ges, H.P., and Redl, H. Fresh autogeneic, frozen allogeneic, and decalcified allogeneic bone-grafts in dogs. J Bone Joint Surg Br 73, 787, 1991.
56. Burchardt, H., and Enneking, W.F. Transplantation of bone. Surg Clin North Am 58, 403, 1978.
57. Johnson, A.L., Eurell, J.A., and Schaeffer, D.J. Evaluation of canine cortical bone-graft remodeling. Vet Surg 21, 293, 1992.
58. Tiyapatanaputi, P., Rubery, P.T., Carmouche, J., Schwarz, E.M., O'Keefe, R.J., and Zhang, X. A novel murine segmental femoral graft model. J Orthop Res 22, 1254, 2004.
59. Turgeman, G., Pittman, D.D., Muller, R., Kurkalli, B.G., Zhou, S., Pelled, G., Peyser, A., Zilberman, Y., Moutsatsos, I.K., and Gazit, D. Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy. J Gene Med 3, 240, 2001.
60. Moutsatsos, I.K., Turgeman, G., Zhou, S., Kurkalli, B.G., Pelled, G., Tzur, L., Kelley, P., Stumm, N., Mi, S., Muller, R., Zilberman, Y., and Gazit, D. Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther 3, 449, 2001.
61. Zilberman, Y., Kallai, I., Gafni, Y., Pelled, G., Kossodo, S., Yared, W., and Gazit, D. Fluorescence molecular tomography enables in vivo visualization and quantification of nonunion fracture repair induced by genetically engineered mesenchymal stem cells. J Orthop Res 26, 522, 2008.
62. Pelled, G., Tai, K., Sheyn, D., Zilberman, Y., Kumbar, S., Nair, L.S., Laurencin, C.T., Gazit, D., and Ortiz, C. Structural and nanoindentation studies of stem cell-based tissue-engineered bone. J Biomech 40, 399, 2007.
63. Tai, K., Pelled, G., Sheyn, D., Bershteyn, A., Han, L., Kallai, I., Zilberman, Y., Ortiz, C., and Gazit, D. Nanobiomechanics of repair bone regenerated by genetically modified mesen-chymal stem cells. Tissue Eng A 14, 1709, 2008.
64. Dazai, S., Akita, S., Hirano, A., Rashid, M.A., Naito, S., Akino, K., and Fujii, T. Leukemia inhibitory factor enhances bone formation in calvarial bone defect. J Craniofac Surg 11, 513, 2000.
65. Gafni, Y., Pelled, G., Zilberman, Y., Turgeman, G., Appa-railly, F., Yotvat, H., Galun, E., Gazit, Z., Jorgensen, C., and Gazit, D. Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system. Mol Ther 9, 587, 2004.
66. Steinhardt, Y., Aslan, H., Regev, E., Zilberman, Y., Kallai, I., Gazit, D., and Gazit, Z. Maxillofacial-derived stem cells regenerate critical mandibular bone defect. Tissue Eng A 14, 1763, 2008.
67. Ashinoff, R.L., Cetrulo, C.L., Galiano, R.D., Dobryansky, M., Bhatt, K.A., Ceradini, D.J., Michaels, J., McCarthy, J.G., and Gurtner, G.C. Bone morphogenic protein-2 gene therapy for mandibular distraction osteogenesis. Ann Plast Surg 52, 585, 2004.
68. Reynolds, D.G., Hock, C., Shaikh, S., Jacobson, J., Zhang, X.P., Rubery, P.T., Beck, C.A., O'Keefe, R.J., Lerner, A.L., Schwarz, E.M., and Awad, H.A. Micro-computed tomography prediction of biomechanical strength in murine structural bone grafts. J Biomech 40, 3178, 2007.
69. van Lenthe, G., Stauber, M., and Müller, R. Specimen-specific beam models for fast and accurate prediction of human trabecular bone mechanical properties. Bone 39, 1182, 2006.
70. Xie, C., Reynolds, D., Awad, H., Rubery, P.T., Pelled, G., Gazit, D., Guldberg, R.E., Schwarz, E.M., O'Keefe, R.J., and Zhang, X.P. Structural bone allograft combined with genetically engineered mesenchymal stem cells as a novel platform for bone tissue engineering. Tissue Eng 13, 435, 2007.
71. Zilberman, Y., Gafni, Y., Pelled, G., Gazit, Z., and Gazit, D. Bioluminescent imaging in bone. Methods Mol Biol 455, 261, 2008.
72. Bar, I., Zilberman, Y., Zeira, E., Galun, E., Honigman, A., Turgeman, G., Clemens, T., Gazit, Z., and Gazit, D. Molecular imaging of the skeleton: quantitative real-time biolu-minescence monitoring gene expression in bone repair and development. J Bone Miner Res 18, 570, 2003.
73. Sonobe, J., Okubo, Y., Kaihara, S., Miyatake, S.I., and Bessho, K. Osteoinduction by bone morphogenetic protein 2-expressing adenoviral vector: application of biomaterial to mask the host immune response. Hum Gene Ther 15, 659, 2004.
74. Yazici, C., Yanoso, L., Xie, C., Reynolds, D.G., Samulski, R.J., Samulski, J., Yannariello-Brown, J., Gertzman, A.A., Zhang, X., Awad, H.A., and Schwarz, E.M. The effect of surface demineralization of cortical bone allograft on the properties of recombinant adeno-associated virus coatings. Biomater-ials 29, 3882, 2008.
75. Einhorn, T. The cell and molecular biology of fracture healing. Clin Orthop 355 (Suppl), S7, 1998.
76. Serganova, I., Ponomarev, V., and Blasberg, R. Human reporter genes: potential use in clinical studies. Nucl Med Biol 34, 791, 2007.
77. Ferrari, F.K., Samulski, T., Shenk, T., and Samulski, R.J. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol 70, 3227, 1996.
78. Russell, D.W. AAV vectors, insertional mutagenesis, and cancer. Mol Ther 15, 1740, 2007.